Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 2/2008

01-12-2008 | Short Report

Three-generational alkaptonuria in a non-consanguineous family

Authors: K. Oexle, K. Engel, S. Tinschert, D. Haas, M. A. Lee-Kirsch

Published in: Journal of Inherited Metabolic Disease | Special Issue 2/2008

Login to get access

Summary

Objective:

Alkaptonuria (AKU) is a rare inborn error of metabolism of aromatic amino acids and considered to be an autosomal recessive trait caused by mutations in the homogentisate 1,2-dioxygenase (HGD) gene. A dominant pattern of inheritance has been reported but was attributed to extended consanguinity in many cases. However, we have observed a non-consanguineous family segregating AKU in a dominant manner over three generations.

Results:

All affected individuals presented with typical features of AKU including darkening of the urine, ochronosis, arthropathy, and elevated urinary excretion of homogentisic acid. Sequence analysis of the HGD gene from genomic DNA of two affected individuals, uncle and niece, revealed a heterozygous missense mutation (M368V) in the uncle that was not present in his niece. Microsatellite genotyping demonstrated that both were heterozygous at the HGD locus and shared one haplotype. This haplotype did not contain a detectable HGD mutation. The haplotype was also found in a healthy son of the niece, making a dominant HGD mutation unlikely. Moreover, sequencing of cDNA from lymphoblastoid cells of the niece did not reveal an HGD mRNA with a potentially dominant-negative effect.

Conclusion:

Rare causes of the uncommon AKU inheritance in this family have to be considered, ranging from the coincidence of undetectable HGD mutations to a dominant mutation of a second, hitherto unknown AKU gene.
Literature
go back to reference Beltran-Valero de Bernabe D, Granadino B, et al (1998) Mutation and polymorphism analysis of the human homogentisate 1,2-dioxygenase gene in alkaptonuria patients. Am J Hum Genet 62: 776–784. doi:10.1086/301805.PubMedCrossRef Beltran-Valero de Bernabe D, Granadino B, et al (1998) Mutation and polymorphism analysis of the human homogentisate 1,2-dioxygenase gene in alkaptonuria patients. Am J Hum Genet 62: 776–784. doi:10.​1086/​301805.PubMedCrossRef
go back to reference Fernández-Cañón JM, Peñalva MA (1995) Molecular characterization of a gene encoding a homogentisate dioxygenase from Aspergillus nidulans and identification of its human and plant homologues. J Biol Chem 270: 21199–21205. doi:10.1074/jbc.270.36.21199.PubMedCrossRef Fernández-Cañón JM, Peñalva MA (1995) Molecular characterization of a gene encoding a homogentisate dioxygenase from Aspergillus nidulans and identification of its human and plant homologues. J Biol Chem 270: 21199–21205. doi:10.​1074/​jbc.​270.​36.​21199.PubMedCrossRef
go back to reference Kacser H, Burns JA (1981) The molecular basis of dominance. Genetics 97: 639–666.PubMed Kacser H, Burns JA (1981) The molecular basis of dominance. Genetics 97: 639–666.PubMed
go back to reference La Du BN (1995) Alkaptonuria. In: Scriver CR, Beaudet AL, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1371–1386. La Du BN (1995) Alkaptonuria. In: Scriver CR, Beaudet AL, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1371–1386.
go back to reference La Du BN, Zannoni VG, Laster L, Seegmiller JE (1958) The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 230: 251–260.PubMed La Du BN, Zannoni VG, Laster L, Seegmiller JE (1958) The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 230: 251–260.PubMed
go back to reference Milch RA (1955) Direct inheritance of alcaptonuria. Metabolism 4: 513–518.PubMed Milch RA (1955) Direct inheritance of alcaptonuria. Metabolism 4: 513–518.PubMed
go back to reference Rodriguez JM, Timm DE, Titus GP, et al (2000) Structural and functional analysis of mutations in alkaptonuria. Hum Mol Genet 9: 2341–2350.PubMed Rodriguez JM, Timm DE, Titus GP, et al (2000) Structural and functional analysis of mutations in alkaptonuria. Hum Mol Genet 9: 2341–2350.PubMed
go back to reference Schuler AM, Gower BA, Matern D, Rinaldo P, Vockley J, Wood PA (2005) Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid β-oxidation. Mol Genet Metab 85: 7–11.PubMedCrossRef Schuler AM, Gower BA, Matern D, Rinaldo P, Vockley J, Wood PA (2005) Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid β-oxidation. Mol Genet Metab 85: 7–11.PubMedCrossRef
go back to reference Titus GP, Mueller HA, Burgner J, Rodriguez de Cordoba S, Penalva MA, Timm DE (2000) Crystal structure of human homogentisate dioxygenase. Nat Struct Biol 7: 542–546. doi:10.1038/76756.PubMedCrossRef Titus GP, Mueller HA, Burgner J, Rodriguez de Cordoba S, Penalva MA, Timm DE (2000) Crystal structure of human homogentisate dioxygenase. Nat Struct Biol 7: 542–546. doi:10.​1038/​76756.PubMedCrossRef
go back to reference Wilcken B, Hammond JW, Howard N, Bohane T, Hocart C, Halpern B (1981) Hawkinsinuria: a dominantly inherited defect of tyrosine metabolism with severe effects in infancy. N Engl J Med 305: 865–868.PubMedCrossRef Wilcken B, Hammond JW, Howard N, Bohane T, Hocart C, Halpern B (1981) Hawkinsinuria: a dominantly inherited defect of tyrosine metabolism with severe effects in infancy. N Engl J Med 305: 865–868.PubMedCrossRef
go back to reference Zatkova A, Beltran Valero de Bernabe D, Polakova H, et al (2000) High frequency of alkaptonuria in Slovakia: evidence for the appearance of multiple mutations in HGO involving different mutational hot spots. Am J Hum Genet 67: 1333–1339.PubMed Zatkova A, Beltran Valero de Bernabe D, Polakova H, et al (2000) High frequency of alkaptonuria in Slovakia: evidence for the appearance of multiple mutations in HGO involving different mutational hot spots. Am J Hum Genet 67: 1333–1339.PubMed
Metadata
Title
Three-generational alkaptonuria in a non-consanguineous family
Authors
K. Oexle
K. Engel
S. Tinschert
D. Haas
M. A. Lee-Kirsch
Publication date
01-12-2008
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue Special Issue 2/2008
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-008-0994-7

Other articles of this Special Issue 2/2008

Journal of Inherited Metabolic Disease 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.